Literature DB >> 1616337

Antiphospholipid antibodies in homozygous sickle cell disease.

K De Ceulaer1, M A Khamashta, E N Harris, G R Serjeant, G R Hughes.   

Abstract

Serum samples from 108 unselected Jamaican patients with homozygous sickle cell disease and 116 control subjects with normal haemoglobin were screened for the presence of antiphospholipid antibodies. Slightly increased levels of IgG antiphospholipid antibodies were found in nine patients with sickle cell disease and in none of the control subjects. Serial control samples confirmed the increased levels of antiphospholipid antibodies. A comparison of the haematological and clinical features of patients with positive and negative antiphospholipid sickle cell disease did not highlight any differences between the groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616337      PMCID: PMC1005705          DOI: 10.1136/ard.51.5.671

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Systemic lupus erythematosus and sickle-cell anaemia.

Authors:  W A Wilson; G D Nicholson; G R Hughes; S Amin; G Alleyne; G R Serjeant
Journal:  Br Med J       Date:  1976-04-03

2.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

3.  Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia.

Authors:  B A Portnoy; J C Herion
Journal:  Ann Intern Med       Date:  1972-04       Impact factor: 25.391

4.  Comparison of phospholipid and fatty acid composition of human erythrocytes and platelets.

Authors:  P Cohen; A Derksen
Journal:  Br J Haematol       Date:  1969-10       Impact factor: 6.998

5.  Functional asplenia in sickle-cell anemia.

Authors:  H A Pearson; R P Spencer; E A Cornelius
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

6.  Recurrent stroke associated with thymoma and anticardiolipin antibodies.

Authors:  S R Levine; I M Diaczok; M J Deegan; S N Kieran; H Feit; S B Elias; K M Welch
Journal:  Arch Neurol       Date:  1987-06

7.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

Authors:  M A Khamashta; E N Harris; A E Gharavi; G Derue; A Gil; J J Vázquez; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

8.  Immunologic and coagulation disorders in chlorpromazine-treated patients.

Authors:  M H Zarrabi; S Zucker; F Miller; R M Derman; G S Romano; J A Hartnett; A O Varma
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

9.  The natural history of stroke in sickle cell disease.

Authors:  D Powars; B Wilson; C Imbus; C Pegelow; J Allen
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

10.  Abnormalities in membrane phospholipid organization in sickled erythrocytes.

Authors:  B Lubin; D Chiu; J Bastacky; B Roelofsen; L L Van Deenen
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more
  2 in total

1.  Lupus anticoagulant and leg ulcers in sickle cell anemia.

Authors:  Edeghonghon E Olayemi; Godwin N Bazuaye
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

2.  Antiphospholipid Antibodies in Sickle Cell Disease: A Systematic Review and Exploratory Meta-Analysis.

Authors:  Mira Merashli; Alessia Arcaro; Maria Graf; Matilde Caruso; Paul R J Ames; Fabrizio Gentile
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.